ImmuCell Corporation
ICCC
$6.52
$0.345.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 181.19% | 173.34% | 54.19% | -249.76% | 61.58% |
| Total Depreciation and Amortization | 0.33% | -0.19% | 0.61% | 0.55% | -1.13% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 5.88% | 0.99% |
| Total Other Non-Cash Items | -40.87% | -19.45% | -46.60% | 71.85% | -56.52% |
| Change in Net Operating Assets | 53.10% | -86.00% | -148.93% | 903.33% | 136.67% |
| Cash from Operations | 50,867.74% | 99.52% | -209.88% | 39.02% | 157.88% |
| Capital Expenditure | -67.74% | -121.95% | 20.14% | -57.24% | 13.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -67.74% | -121.95% | 16.76% | -50.85% | -308.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.58% | -1.60% | -1.07% | -0.80% | -1.32% |
| Issuance of Common Stock | -97.62% | -77.24% | 1,316.82% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.26% | -- | -- | 100.00% | -130.12% |
| Cash from Financing | -371.05% | -95.36% | 2,978.23% | 69.55% | -14.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,768.85% | -102.03% | 582.69% | 2,077.72% | 98.18% |